Masked Hypertension and Incident Clinic Hypertension Among Blacks in the Jackson Heart Study

Marwah Abdalla1, John N Booth2, Samantha R Seals2

  • 1From the Department of Medicine, Columbia University Medical Center, New York, NY (M.A., K.M.D., D.S.); Department of Epidemiology, University of Alabama at Birmingham (J.N.B., P.M.); Center of Biostatistics and Bioinformatics, Department of Preventive Medicine (S.R.S.) and Department of Medicine (M.S.), University of Mississippi Medical Center, Jackson; Department of Population Health, NYU School of Medicine, NY (T.M.S.); and Hypertension Research Program, Department of Family Medicine, University of North Carolina at Chapel Hill (A.J.V.). ma2947@cumc.columbia.edu.

Insights

Masked hypertension, where clinic blood pressure is normal but out-of-clinic readings are high, significantly increases the risk of developing high blood pressure. Ambulatory blood pressure monitoring can identify Black individuals at higher risk.

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Public Health

Background:

  • Masked hypertension, characterized by normal clinic blood pressure (BP) and elevated out-of-clinic BP, may represent an intermediate stage in hypertension development.
  • Ambulatory BP monitoring (ABPM) is crucial for detecting masked hypertension, particularly in at-risk populations.

Purpose of the Study:

  • To investigate the association between masked hypertension, identified via ABPM, and the incidence of clinic hypertension in a Black cohort.
  • To determine if different types of masked hypertension (daytime, nighttime, 24-hour) predict future hypertension development.

Main Methods:

  • Prospective cohort study (Jackson Heart Study) including 317 Black participants with baseline clinic BP <140/90 mmHg and no antihypertensive medication.
  • ABPM used to define masked hypertension (daytime ≥135/85, nighttime ≥120/70, 24-hour ≥130/80 mmHg).
  • Incident clinic hypertension defined as clinic BP ≥140/90 mmHg or antihypertensive medication use during follow-up (median 8.1 years).

Main Results:

  • A high incidence of clinic hypertension (59.0%) was observed during follow-up.
  • Participants with any masked hypertension had a 2.13-fold increased risk of developing clinic hypertension (HR: 2.13, 95% CI: 1.51-3.02).
  • Specific types of masked hypertension, particularly nighttime masked hypertension (HR: 2.22, 95% CI: 1.58-3.12), were significantly associated with increased risk.

Conclusions:

  • ABPM is a valuable tool for identifying Black individuals with masked hypertension who are at elevated risk of developing sustained clinic hypertension.
  • Early detection and intervention for masked hypertension may be critical for preventing future hypertension and cardiovascular events in this population.

Related Concept Videos

Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...